What is the price-to-earnings ratio of Analytica?
The price-earnings ratio of Analytica is currently -2.
Analytica P/E 2024
Analytica P/E
-2
Ticker
ALT.AX
ISIN
AU000000ALT0
WKN
A0ESJV
As of Sep 13, 2024, Analytica's P/E ratio was -2, a -71.83% change from the -7.1 P/E ratio recorded in the previous year.
The Analytica P/E history
Analytica Aktienanalyse
What does Analytica do?
Analytica Ltd is a British company that was founded in 1970 by Dr. John Smith. Originally, it specialized in the development of analysis instruments for the chemistry and life sciences, particularly liquid chromatography. Over the years, the company expanded its offerings and now provides a wide range of products and services. Analytica Ltd has become a global company with a presence in over 130 countries. It operates in various business areas, including analytical chemistry, bioanalysis, environmental and food analysis, and clinical diagnostics. The company offers customers a wide range of products, such as chromatography systems, mass spectrometers, specialized analysis devices, and consumables. It has also specialized in the development and manufacturing of medical devices, including diagnostic tools for conditions such as diabetes, cholesterol, and other metabolic diseases. Analytica Ltd incorporates innovative technologies like miniaturization and nanotechnology into its products. In addition to product sales, Analytica Ltd provides tailored services. The company has highly qualified experts who assist customers with method development, process optimization, and data interpretation. It also conducts research and development programs to continuously develop new products and technologies. Analytica Ltd maintains numerous collaborations and partnerships with other companies and organizations. For example, it works closely with research institutions and universities to develop new technologies and products. The company also connects with other companies in the health and analytical industries to share innovations and best practices. Overall, Analytica Ltd is a leading provider of analysis solutions for the pharmaceutical, biotech, chemical, and food industries, as well as research institutions and clinical laboratories. The company is continuously working to further develop its products and services to meet the needs of its customers and address the ever-changing challenges of the industry. Analytica ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Analytica's P/E Ratio
The Price to Earnings (P/E) Ratio of Analytica is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Analytica's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Analytica is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Analytica’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Analytica stock
How has the price-earnings ratio of Analytica changed compared to last year?
The price-to-earnings ratio of Analytica has increased by -71.83% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Analytica high compared to other companies?
Yes, the price-to-earnings ratio of Analytica is high compared to other companies.
How does an increase in the price-earnings ratio of Analytica affect the company?
An increase in the price-earnings ratio of Analytica would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Analytica affect the company?
A decrease in the price-earnings ratio of Analytica would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Analytica?
Some factors that influence the price-earnings ratio of Analytica are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Analytica pay?
Over the past 12 months, Analytica paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Analytica is expected to pay a dividend of 0 AUD.
What is the dividend yield of Analytica?
The current dividend yield of Analytica is .
When does Analytica pay dividends?
Analytica pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Analytica?
Analytica paid dividends every year for the past 0 years.
What is the dividend of Analytica?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Analytica located?
Analytica is assigned to the 'Health' sector.
Wann musste ich die Aktien von Analytica kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Analytica from 9/13/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.
When did Analytica pay the last dividend?
The last dividend was paid out on 9/13/2024.
What was the dividend of Analytica in the year 2023?
In the year 2023, Analytica distributed 0 AUD as dividends.
In which currency does Analytica pay out the dividend?
The dividends of Analytica are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Analytica
Our stock analysis for Analytica Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Analytica Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
